Skip to main content
Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
15.74
+0.14 (0.90%)
At close: Mar 6, 2026, 4:00 PM EST
15.44
-0.30 (-1.91%)
After-hours: Mar 6, 2026, 7:44 PM EST

Cullinan Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
111
Market Cap
929.86M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 202118.94M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortrea Holdings 2.72B
Valneva SE 211.09M
Maravai LifeSciences Holdings 185.74M
Geron 183.88M
ARS Pharmaceuticals 142.77M
uniQure 16.10M
Aktis Oncology 5.56M
Compass Therapeutics 850.00K
Revenue Rankings

CGEM News

More News